ScholarLens Back to search
2016•DEStech Transactions on Social Science Education and Human ScienceRequires access

Expression of Soluble Endoglin and sFlt-1 in Peripheral Blood of Preeclampsia

Minghua Fan, Yongping Xu, Jianqing Qiu

Open publisher page 0 citations

Abstract

Objective To investigate the expression and significance of serum soluble endoglin (sEng) and soluble fms-like tyrosine kinase 1 (sFlt-1) in preeclampsia. Methods Serum levels of sEng 1 and sFlt-1 were determined by enzyme linked immunosorbent assay. Results The serum level of sEng of the preeclampsia group (6.39±2.15) ng/ml was significantly higher than that of the control (2.16±0.31) ng/ml, P<0.01, especially of early-onset severe preeclampsia. The serum level of sFlt-1 of the preeclampsia group (411.11±80.19) pg/ml was significantly higher than that of the third trimester group (27.57±4.36) pg/ml, but sFlt-1 did not correlate with the most severe forms of the disease. Conclusion Serum levels of sEng and sFlt-1 are significantly increased in preeclampsia, and the serum level of sEng is even higher in severe preeclampsia patients.

About this research paper

What this paper is about

Objective To investigate the expression and significance of serum soluble endoglin (sEng) and soluble fms-like tyrosine kinase 1 (sFlt-1) in preeclampsia. Methods Serum levels of sEng 1 and sFlt-1 were determined by enzyme linked immunosorbent assay. Results The serum level of sEng of the preeclampsia group (6.39±2.15) ng/ml was significantly higher than that of the control (2.16±0.31) ng/ml, P<0.01, especially of early-onset severe preeclampsia. The serum level of sFlt-1 of the preeclampsia group (411.11±80.19) pg/ml was significantly higher than that of the third trimester group (27.57±4.36) pg/ml, but sFlt-1 did not correlate with the most severe forms of the disease. Conclusion Serum levels of sEng and sFlt-1 are significantly increased in preeclampsia, and the serum level of sEng is even higher in severe preeclampsia patients.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the expression and significance of serum soluble endoglin (sEng) and soluble fms-like tyrosine kinase 1 (sFlt-1) in preeclampsia. Methods Serum levels of sEng 1 and sFlt-1 were determined by enzyme linked immunosorbent assay. Results The serum level of sEng of the preeclampsia group (6.39±2.15) ng/ml was significantly higher than that of the control (2.16±0.31) ng/ml, P<0.01, especially of early-onset severe preeclampsia. The serum level of sFlt-1 of the preeclampsia group (411.11±80.19) pg/ml was significantly higher than that of the third trimester group (27.57±4.36) pg/ml, but sFlt-1 did not correlate with the most severe forms of the disease. Conclusion Serum levels of sEng and sFlt-1 are significantly increased in preeclampsia, and the serum level of sEng is even higher in severe preeclampsia patients.

Key concepts: Preeclampsia, Medicine, Endoglin, Internal medicine, Peripheral blood, Soluble fms-like tyrosine kinase-1, Endocrinology, Pregnancy

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Expression of Soluble Endoglin and sFlt-1 in Peripheral Blood of Preeclampsia — Research Paper | ScholarLens